secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001213900-25-001211
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma agrees to reduce warrant exercise price to $0.40 for 1.03M shares, raising $412k
--------------------------------------------------------------------------------

- Lind Global Fund exercises 1,029,167 warrants at reduced price of $0.40/share, generating $411,666.80 in proceeds.
- The company agrees to a 15-day standstill on further common stock issuances, with exceptions for employee plans and strategic transactions.
- Resale of the underlying shares is already registered on Form S-1 (File 333-280411).
- Company reimburses $3,000 of Holder's legal fees, withheld from exercise proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025001211/0001213900-25-001211-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025001211/ea0226487-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-001211

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer